Cargando…
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Virus neutralization remains the gold standard for determining antibody efficacy. Therefore, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently needed for COVID-19 serodiagnosis, convalescent plasma therapy, and vaccine development. Here we report on a fluorescence-bas...
Autores principales: | Muruato, Antonio E., Fontes-Garfias, Camila R., Ren, Ping, Garcia-Blanco, Mariano A., Menachery, Vineet D., Xie, Xuping, Shi, Pei-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263515/ https://www.ncbi.nlm.nih.gov/pubmed/32511386 http://dx.doi.org/10.1101/2020.05.21.109546 |
Ejemplares similares
-
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Muruato, Antonio E., et al.
Publicado: (2020) -
Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Muruato, Antonio E., et al.
Publicado: (2021) -
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test
por: Xie, Xuping, et al.
Publicado: (2021) -
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Shi, Pei-Yong, et al.
Publicado: (2021) -
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xie, Xuping, et al.
Publicado: (2020)